Page 3 - Kim Sang Bong News Today : Breaking News, Live Updates & Top Stories | Vimarsana

After the government unveiled a plan to inoculate 10 million high-risk people by July
Reuters
January 28, 2021
People wearing masks stand before a zebra crossing on a cold winter day amid the coronavirus disease (Covid-19) pandemic in Seoul, South Korea, January 7, 2021. PHOTO: REUTERS
SEOUL:
South Korea will review the use of AstraZeneca’s Covid-19 vaccine for the elderly because of limited efficacy data, the government said on Thursday, as it unveiled a plan to inoculate 10 million high-risk people by July.
Vaccinations will be expanded towards the second half of the year to include the general public with a goal of reaching herd immunity by November, Korea Disease Control and Prevention Agency (KDCA) director Jeong Eun-kyeong told a news briefing. ....

South Korea , Soult Ukpyolsi , Astrazeneca Covid , Johnson Janseen , Johnson Janssen , Jeong Eun Kyeong , Prevention Agency , World Health , Pfizer Inc , Moderna Inc , Ministry Of Food , Korea Disease Control , Drug Safety , Kim Sang Bong , World Health Organization Backed , தெற்கு கொரியா , ஜான்சன் ஜான்சன் , ஜியோங் ஏன் கியோங் , உலகம் ஆரோக்கியம் , ஃபைசர் இன்க் , மாடர்னா இன்க் , அமைச்சகம் ஆஃப் உணவு , கொரியா நோய் கட்டுப்பாடு , மருந்து பாதுகாப்பு , கிம் பாடினார் போங் ,